Cooper Companies (COO) Issues FY19 Earnings Guidance

Cooper Companies (NYSE:COO) updated its FY19 earnings guidance on Thursday. The company provided EPS guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.08. The company issued revenue guidance of $2.60-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY 2019 guidance to $11.30-11.70 EPS.

A number of analysts have recently commented on the company. Jefferies Financial Group boosted their price target on Cooper Companies to $305.00 and gave the company a buy rating in a report on Friday. ValuEngine upgraded Cooper Companies from a hold rating to a buy rating in a report on Thursday, September 27th. BMO Capital Markets boosted their price target on Cooper Companies from $294.00 to $306.00 and gave the company an outperform rating in a report on Friday. Zacks Investment Research restated a hold rating and issued a $285.00 price target on shares of Cooper Companies in a report on Monday, November 12th. Finally, Oppenheimer set a $270.00 price target on Cooper Companies and gave the company a hold rating in a report on Friday, August 31st. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Cooper Companies presently has an average rating of Buy and a consensus target price of $284.50.

COO opened at $243.01 on Friday. Cooper Companies has a 52-week low of $216.47 and a 52-week high of $283.18. The stock has a market cap of $13.61 billion, a P/E ratio of 21.13, a P/E/G ratio of 2.13 and a beta of 0.77. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 6th. The medical device company reported $2.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.96 by ($0.09). Cooper Companies had a return on equity of 17.86% and a net margin of 5.52%. The company had revenue of $651.50 million for the quarter, compared to the consensus estimate of $645.25 million. During the same quarter in the previous year, the company posted $2.65 EPS. The business’s revenue was up 16.0% on a year-over-year basis. Equities research analysts predict that Cooper Companies will post 12.1 EPS for the current year.

In related news, VP Randal Golden sold 1,731 shares of the company’s stock in a transaction dated Thursday, September 27th. The stock was sold at an average price of $275.86, for a total transaction of $477,513.66. Following the sale, the vice president now owns 1,154 shares in the company, valued at $318,342.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Allan E. Rubenstein sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.37, for a total value of $398,055.00. Following the transaction, the director now directly owns 3,068 shares in the company, valued at approximately $814,155.16. The disclosure for this sale can be found here. Insiders have sold 20,691 shares of company stock worth $5,527,869 in the last quarter. 1.60% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Cooper Companies (COO) Issues FY19 Earnings Guidance” was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: What is the Consumer Price Index (CPI)?

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with's FREE daily email newsletter.

Leave a Reply